BREAKTHROUGH T1D
Clinical Trials Advancing Metabolic Therapies for T1D RFA
Clinical Trials Advancing Metabolic Therapies for T1D RFA is a funding opportunity from BREAKTHROUGH T1D, up to $64.5M. Its application deadline is not stated in the source record.
We could not verify this deadline.
This listing carries no application deadline we can confirm, so it may no longer be open. Check the official solicitation before investing time, and create a free account to see opportunities we can verify are live.
Overview
Breakthrough T1D Request for Applications: Clinical Trials Advancing Metabolic Therapies for T1D Summary * The goal of this funding opportunity is to target metabolic imbalances to improve glucometabolic outcomes in people with established type 1 diabetes (T1D). * This funding opportunity will prioritize T1D…